Ondansetron
Product Images NDC 68071-2865

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2865 5)

Label for Ondansetron 8mg orally disintegrating tablets by NuCare Pharmaceuticals, Inc. The label includes the NDC 68071-2865, package size of 15 tablets, and instructions for use. Manufacturer information lists Aurobindo Pharma Limited in India. The label warns to keep out of reach of children and store at controlled temperature 68-77°F. It also includes batch, serial, expiration, and barcoding details.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron, showing its molecular framework with distinct functional groups and ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.